Aldevron LLC.

Every breakthrough in genomic medicine is measured by the patients it reaches. Aldevron supports innovators at every stage, helping bring transformative therapies closer to the people who need them most.

Aldevron is a leading CDMO partner for genomic medicine, delivering integrated plasmid DNA, RNA, and protein solutions from research through cGMP manufacturing. By combining deep scientific expertise with a unified quality system, Aldevron helps developers reduce complexity, minimize handoffs, and progress programs with greater speed and confidence.

Aldevron has contributed to multiple industry firsts, including pioneering the GMP-Source™ quality system, bridging research and GMP grades with scalable, regulatory-ready solutions, supplying Cas9 for the first CRISPR-enabled therapy and supporting the first CAR‑T cell therapy, and manufacturing drug product for a personalized mRNA-based CRISPR therapy

Whether advancing gene editing, cell therapy, or mRNA programs, Aldevron enables scientists to move faster—from sequence to therapy—without compromise.